Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

NCT01059344 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
281
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tillotts Pharma AG